Serono takes itself off the block

Article Abstract:

Serono AG of Switzerland has ended talks to be acquired as offers have not reflected the companies true value according to the major shareholder the Bartelli family. Stock price has been inconsistent and slid 8.4 percent yesterday to 845 Swiss Francs ($649). The company had been on the block for the past five months.

Acquisitions & mergers, Mergers, acquisitions and divestments, Company acquisition/merger, Serono AG, Company overview

---

Serono's net profit rises 72% on lower costs

Article Abstract:

Serono S.A. of Switzerland posted a soaring 72 percent increase to $144.1 million in net profit. Revenue fell 1.4 percent to $669.9 million. Good returns were due to lower costs and speculation that the pharmaceutical company will be acquired.

Company Profile, Merck Serono S.A.

---

Novartis posts 4.1% rise in earnings

Article Abstract:

Pharmaceutical company Novartis AG's second quarter profits rose 4.1% due to increased sales of cancer and heart drugs. The company is forecasting continued strong growth, and record sales and earnings for the year.

Forecasts, trends, outlooks, Novartis AG, Company business forecast/projection, Company forecasts, NVTSY

Similar abstracts:

• Abstracts: An econometric analysis of the European Commission's merger decisions. Vertical antitrust policy as a problem of inference
• Abstracts: Snohetta: A northern light. Sturgis Associates. Aedas
• Abstracts: Microsoft bares code to avoid fines. Microsoft detaches Windows from Media Player in Europe
• Abstracts: Boeing moves to solve 787 delays. EADS net falls on higher costs, exchange rates
• Abstracts: Europe's banks find bold moves lead to outcry. Stage gets set for Italy's banks to consolidate

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.